[Report] Bioring SA Product Pipeline Analysis TOC

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Financial Performance 7
2.3 Industry Outlook -- Cardiovascular Devices 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
6.2 Other Locations & Subsidiaries 11
7 Bioring SA Pipeline Products 13
7.1 Bioring SA Product Pipeline Analysis 13
7.1.1 Bioring SA Pipeline Products By Equipment Type 13
7.1.2 Bioring SA Pipeline Products By Development Stage 14
7.1.3 Bioring SA Pipeline Products By Therapy Area 15
7.2 Biodegradable coronary stent 15
7.2.1 Product Description 15
7.2.2 Product Status 15
7.3 Biodegradable membrane 15
7.3.1 Product Description 16
7.3.2 Product Status 16
7.4 Uroshield-Intra Urethralbiodegradable Stent 16
7.4.1 Product Description 16
7.4.2 Product Status 16
7.5 Biowing 16
7.5.1 Product Description 17
7.5.2 Product Status 17
8 Appendix 18
8.1 Methodology 18
8.1.1 Coverage 18
8.1.2 Secondary Research 19
8.1.3 Primary Research 19
8.1.4 Expert Panel Validation 20
8.2 Contact Us 20
8.3 About Global Markets Direct 20
8.4 Disclaimer 20

1.1 List of Tables
Table 1: Bioring SA,Key Facts 7
Table 2: Bioring SA, Key Employees, 10
Table 3: Bioring SA, Other Locations 11
Table 4: Bioring SA Pipeline Products by Equipment Type 13
Table 5: Bioring SA Pipeline Products By Development Stage 14
Table 6: Bioring SA Pipeline Products By Therapy Area 15

1.2 List of Figures
Figure 1: Bioring SA Pipeline Products By Development Stage 14
Figure 2: Global Markets Direct Methodology 18